Beyond the Drug Patent Cliff: How Procurement Can Drive Immediate Savings with Generics and Biosimilars
In the high-stakes world of pharmaceutical procurement, the looming “patent cliff” isn’t just a looming threat—it’s a seismic shift demanding immediate strategic action. As blockbuster drugs face patent expirations, the industry braces for a wave of ge…
